| HS Code | 913268 |
| Name | Vitamin K2 |
| Type | dietary supplement |
| Main Ingredient | menaquinone |
| Form | capsule |
| Dosage Strength | 100 mcg |
| Source | synthetic |
| Color | light yellow |
| Taste | neutral |
| Shelf Life | 24 months |
| Storage Condition | cool, dry place |
| Intended Use | supports bone and cardiovascular health |
| Allergen Info | free from gluten, dairy, soy |
| Manufacturer Country | USA |
As an accredited Vitamin K2 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, opaque plastic bottle containing **100 capsules** of Vitamin K2, labeled with dosage, usage instructions, and safety warnings, tamper-evident seal. |
| Shipping | Vitamin K2 is shipped in tightly sealed containers, protected from light, heat, and moisture. It is classified as a non-hazardous material but should be handled with standard safety precautions. During transportation, it should be kept at controlled temperatures, typically below 25°C, to maintain stability and ensure product integrity. |
| Storage | Vitamin K2 should be stored in a cool, dry place, away from direct sunlight, heat, and moisture. Ideally, keep it at room temperature, between 15°C and 25°C (59°F–77°F). Ensure the container is tightly closed and protected from air to prevent degradation. Keep out of reach of children and avoid freezing or excessive humidity to maintain its stability and potency. |
Competitive Vitamin K2 prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Vitamin K2 has come to the forefront in recent years, not because of marketing hype, but because of real demand for products that support bone health and cardiovascular function. From the perspective of a chemical manufacturer heavily invested in both research and production, the evolution of this molecule’s role in health products matters to us because it squares with feedback from partners who formulate dietary supplements, fortified foods, and even specialized animal feeds. Unlike many single-use ingredients, Vitamin K2, especially in its MK-7 and MK-4 forms, finds direct interest among both producers and end-users interested in more natural approaches to health maintenance.
Among K-vitamins, K2 stands apart. Vitamin K1, which appears most commonly in green leafy vegetables, primarily supports normal blood clotting. Vitamin K2, on the other hand, moves deeper into the cycle of human wellbeing—its most studied role involves supporting calcium metabolism, ensuring that calcium is shuttled to the bones and kept out of blood vessels. This distinction drives not only interest among supplement formulators, but also adds pressure on manufacturers like us to maintain purity and stability, particularly for MK-7, which shows the longest half-life in the bloodstream and has become widely sought after in premium supplement blends.
We start with the practical foundation that the high-performance Vitamin K2 ingredients today require either fermentation-based extraction or synthesis. In today’s market, natural fermentation has emerged as the preferred method for generating MK-7, mainly because it mirrors how natto (a traditional Japanese food) naturally contains this nutrient at high levels. Chemical synthesis remains an option for some forms, particularly MK-4, but many supplement producers lean towards fermentation-derived K2 due to perception and labeling preferences.
The fermentation process requires careful control over bacterial cultures and feedstocks. Over years of scaling up, we have observed that even a small deviation in fermentation temperature, nutrition, or aeration changes the yield and purity profile of the batch. Post-fermentation, extraction selects out K2 from a soup of natural by-products. Here, purity must reach above 98 percent for health food applications, taking us through filtration, fractionation, and sometimes molecular distillation—a task that hinges on deep process know-how. Neither staff nor machines deliver consistency by chance. Training, process analytics, and vigilance over residues make all the difference. One failed batch can mean not only financial loss, but delayed delivery and disappointed formulation customers who are depending on reliable input.
Producers using Vitamin K2—whether for dietary supplements, fortified dairy, or animal nutrition—insist on documentation and traceability for every batch. Our most popular lineup consists of MK-7 crystal (>98% purity), MK-7 oil (20% and 50% concentration, typically stabilized in MCT oil), and MK-4 crystalline powder. Each comes with its own stability considerations, storage preferences, and practical shelf-life, so we design packaging and logistics to match usage needs.
From a manufacturer’s perspective, the difference between delivering K2 MK-7 at 1% versus a 20% oil-based formulation is not simply a matter of dilution. The carrier oil, whether MCT or sunflower, must be neutral in taste, food-grade, non-reactive with the active, and not accelerate degradation even after months on a truck or warehouse shelf. Moisture content is kept as low as feasible, because even small amounts increase the risk of degradation, especially for high-purity, crystalline products.
Among all available forms, MK-7 draws the most attention in bone and cardiovascular health formulations, particularly because its bioavailability sustains functional concentrations in the body longer than MK-4. Our production lines supply both, but in different ways: MK-7 through bacterial fermentation, and MK-4 predominantly through organic synthesis or conversion processes. Each form brings its own price structure, technical demands, and processing realities.
In direct feedback from customers who build their business on clinical support or regulatory approval, the choice—MK-4 or MK-7—often depends on labeling regulations in the target market, as well as evidence for health claims. As a manufacturer, we focus our resources on making sure whichever form leaves our factory has gone through rigorous testing, confirming purity, isomeric content (for MK-7, trans isomer is the active form), and stability under anticipated storage conditions.
Our plant operates certified food-grade production lines. This might sound simple, but open vats and exposure to environmental microbes scream risk: unwanted bacterial growth, cross-contamination, or accidental inclusion of unknown residues. We control each variable tightly, investing in filtration systems and environmental controls, which results in consistent lots and meets demands from customers manufacturing finished dosage forms around the world.
The analytical work does not stop at purity. We verify contaminants—including polychlorinated biphenyls (PCBs), residual solvents, and heavy metals—per accepted international thresholds. Our technical teams monitor each lot with HPLC and mass spectrometry, and send documentation with every shipment. Some of our production runs undergo stability testing at both standard (25°C, 60% RH) and accelerated (40°C, 75% RH) conditions. Based on these, we confidently offer dating and optimal storage instructions that reflect real risk assessment instead of generic guidelines.
Many manufacturers produce Vitamin K2, but we notice key differences every time we analyze incoming materials from elsewhere. The main variables: isomeric purity (particularly relevant for MK-7), degradation products, and stability after blending into finished products.
More than once, third-party K2 samples have included significant cis isomer contamination, which brings active content down and may confuse quality control further down the chain. Some producers use stabilizers outside of officially allowed food additive lists, or cut corners on filtration and purification, resulting in visible residues or off-colors. We maintain strict adherence to both legal and internal standards not only because of regulatory audits, but because repeat customers will immediately notice if a batch leads to flavor carry-over, inconsistent potency, or issues during blending.
Compared with other nutrients in the fat-soluble vitamin space, Vitamin K2 imposes one of the toughest stabilization challenges. Vitamin D3, for instance, is less sensitive to oxygen but degrades under light. Vitamin K2 degrades due to oxygen, heat, moisture, and, in the case of MK-7, can even undergo isomerization if exposed to poor storage conditions. Our stabilization protocols draw on years of feedback and internal research, using oxygen-absorbing agents and careful packaging designed for extended shelf life under realistic transit and storage scenarios.
Formulators working with our customers tend to ask about flow properties, particle size, and blending characteristics—not because they love specifications, but because mixing K2 at a low dose with high precision is no simple job. Uniform dispersion means careful sieving and particle engineering. One of our early lessons as we moved beyond pilot batches: a crystalline powder that looks fine to the naked eye can clump or segregate unless treated with anti-caking agents or presented as a microencapsulated powder.
Our in-house teams have experimented with several approaches, comparing microencapsulation, oil dispersions, and blends with inert carriers. Each strategy brings a new set of trade-offs. For instance, some tablet producers choose the oil version for flexibility during production scale-up, while others specify a stabilized powder to hold up under multiple months of high humidity shipping conditions. The growing trend towards allergen-free and vegan certifications in final products means every excipient counts, directing our R&D toward clean-label solutions without sacrificing product strength or shelf life.
Regulatory frameworks for Vitamin K2 differ country to country, and sometimes even across regional lines. We comply with both US FDA and European Food Safety Authority positions on allowable forms and dosages. As an ingredient manufacturer with global distribution, we keep up with changing standards not out of simple compliance, but so our customers avoid hold-ups in formulation or market entry.
The US sets a Dietary Reference Intake (DRI) for Vitamin K (including both K1 and K2), while the EU lists MK-7 under its permitted forms for food supplements. Our records and batch release documents specify labeling requirements for all intended markets. Orders destined for Asian partners usually require supplemental documentation, such as GMO statements and clean country-of-origin attestations, so we invest in traceable sourcing and up-to-date paperwork. Besides, in many markets, local authorities demand evidence of natural origin (for fermented MK-7), so we developed audit trails and in-house testing to support these claims.
Competition for Vitamin K2 feedstocks has increased lately as both synthetic and natural sources face cost pressures. For our fermentation processes, we have adjusted our input sourcing to reduce waste and participate in verified supply chains. By optimizing media composition and working with partners on transportation and logistics, our factory has trimmed unnecessary energy use and environmental impact.
We have also moved away from certain palm-based carriers in favor of coconut or fully synthetic alternatives, responding to both customer feedback and regulatory preference. Sometimes these changes inflate costs or lengthen development timelines, but the reward is stronger relationships with customers focused on corporate sustainability goals. Reliability does not come from overnight changes, but from a habit of scrutinizing inputs and vetting new suppliers as regulations and market preferences change.
Every year brings new requests. Higher concentrations of MK-7, extended shelf life, allergen-free processing, non-GMO certification, or simply improved taste-neutrality in finished products. Some customers demand tailored solubility matrices for inclusion in complex health products, which pushes our technical teams to refine microencapsulation and carrier selection. Years ago, few cared about sustainable palm oil in MCT carriers; now an increasing fraction requires palm-free as a contract term.
Rumors and reports periodically arise about K2 shortages or contamination issues. Our response as direct manufacturers involves transparent documentation, customer-facing batch samples, and continued investment in newer analytical techniques. Customer audits are welcome, since they provide both external validation and new perspectives on improvement.
Scientists keep generating new data around Vitamin K2’s health value—studies linking regular MK-7 supplementation to improved arterial flexibility, or MK-4 to potential adjunctive therapy in bone metabolism disorders. Prospective clinical research in cognitive aging and cellular energy processes is emerging but remains quieter in the mainstream. As manufacturers, we must stay aware of these developments, both to answer ingredient-specific questions and to ensure our product matches what clinical researchers are studying.
Over the years, direct collaboration with universities and testing laboratories has brought us evidence-based feedback—how our material performs in finished-products, impacts stability, or enables tighter dosing claims. We are kept on our toes by partners who share upcoming clinical endpoints and need precise batch-matched samples. The relationship between manufacturing quality and scientific discovery becomes closer every season, and any consistent manufacturer is forced to listen if they want to remain relevant as the science advances.
We run audits not because the law requires it, but because the practical cost of a quality failure is higher than what most labels show. In our own history, responding to out-of-spec returns led to months of technical fixes and retraining. It became obvious that document control, record keeping, and regular chemical analysis protect both our partners and our reputation.
In the context of Vitamin K2, this diligence spells out as consistency not only from batch to batch, but over multi-year cycles. Formulators in the supplement and functional food sectors have long supply chains. A shift in supplier quality or source impacts every player downstream. Our role is to provide stable, well-documented materials that match global standards, support health claims, and work in the factory setting where temperature, humidity, and handling cannot always be tightly managed.
Every production run of Vitamin K2 brings reminders that manufacturing is more than dialing in chemical reactions or fermentation times. It calls for coordination across science, regulation, and real-world supply chain demands. Model numbers carry less meaning in Vitamin K2 than raw details: batch tracking, purity percentage, isomer ratio, contaminant profile, and origin. Each customer—whether a maker of chewable tablets, a dairy fortifier, or an animal nutrition blender—wants assurance about what they are putting into their brands.
The ingredient itself changes little on paper from manufacturer to manufacturer, but experience teaches that the difference lies in attention to the processing steps, the accuracy of documentation, and the ability to adjust to regulatory and customer pressure. As new applications for Vitamin K2 surface, from functional confectioneries to specialized medical foods, we continue adapting our processes, product forms, and supply chain transparency to meet realistic, field-tested expectations.
Producing high-quality Vitamin K2 involves coordination at every step—fermentation, extraction, purification, blending, packaging, testing, and logistics. Each year as customer requirements shift and regulations adapt, we refine and sometimes reinvent our procedures on the production floor. Our commitment to understanding application needs—not just compliance on paper—shapes our product so that it matches the demands of real-world formulation and long shelf life. This continuous dialogue between our technical teams, quality systems, and formulation customers ensures that each batch emerges informed by science, shaped by end use, and meets the mark for safety and consistency worldwide.